Pantanu-I

Pantanu-I is a combination formulation containing pantoprazole sodium 40 mg as enteric-coated pellets and itopride 150 mg as sustained-release pellets. It combines acid suppression with prokinetic activity and may be prescribed for selected gastrointestinal conditions when both ingredients are clinically appropriate.

📋 COMPOSITION
Pantoprazole Sodium 40mg (as Enteric Coated Pellets) + Itopride Hydrochloride 150mg (as Sustained Release Pellets)

💊 DOSAGE FORM
Capsule

📦 PACKAGING TYPE
Alu Alu

🗃️ PACKAGING
10X10

Description

Pantanu-I is a combination formulation containing pantoprazole sodium 40 mg as enteric-coated pellets and itopride 150 mg as sustained-release pellets. It combines acid suppression with prokinetic activity and may be prescribed for selected gastrointestinal conditions when both ingredients are clinically appropriate.

Pantoprazole helps reduce stomach acid production, while itopride supports upper gastrointestinal motility. A healthcare professional should assess the patient’s symptoms, medical history and other medicines before recommending this combination.

Therapeutic Segment

Gastrointestinal Care | Acid Reflux Management | Prokinetic Therapy

Uses of Pantanu-I

A healthcare professional may prescribe Pantanu-I for selected gastrointestinal conditions where acid suppression and improved upper gastrointestinal motility are both considered appropriate, including:

  • Gastroesophageal reflux symptoms.
  • Acid-related upper gastrointestinal discomfort.
  • Selected symptoms associated with functional dyspepsia, such as post-meal fullness or upper abdominal discomfort, when clinically indicated.

The appropriate indication depends on the patient’s diagnosis and the approved product information.

Key Benefits

  • Acid suppression: Pantoprazole reduces gastric acid production.
  • Motility support: Itopride helps support upper gastrointestinal movement.
  • Combined mechanism: Brings together a proton pump inhibitor and a prokinetic ingredient.
  • Pellet-based formulation: Uses enteric-coated pantoprazole pellets and sustained-release itopride pellets, as specified in the supplied composition.

The combination may not be suitable for every patient, and symptom improvement is not guaranteed.

How Pantanu-I Works

Pantoprazole sodium 40 mg belongs to the proton pump inhibitor (PPI) class. It inhibits the proton pumps responsible for gastric acid secretion, helping reduce acid production.

Itopride 150 mg is a prokinetic medicine. It works primarily through dopamine D2 receptor antagonism and acetylcholinesterase inhibition, helping increase acetylcholine activity and support gastrointestinal motility.

The supplied formulation describes pantoprazole as enteric-coated pellets and itopride as sustained-release pellets. Follow the approved product label for the exact release characteristics and administration instructions.

Possible Side Effects

Possible side effects may include:

  • Abdominal discomfort
  • Diarrhoea or constipation
  • Nausea
  • Headache
  • Dizziness

Side effects vary between individuals. Seek medical advice if symptoms are severe, persistent or unusual. Promptly report symptoms such as unexplained breast milk production or menstrual changes, as itopride may affect prolactin levels in some patients.

Important Safety Information

  • Use Pantanu-I only under the guidance of a qualified healthcare professional.
  • Inform your prescriber about existing medical conditions, allergies and all medicines or supplements you take.
  • Itopride may not be suitable for patients with gastrointestinal bleeding, mechanical obstruction or perforation, because stimulating gastrointestinal movement may be inappropriate in these conditions.
  • Tell your healthcare professional if you have liver or kidney problems or have experienced adverse reactions to similar medicines.
  • Consult a healthcare professional before use during pregnancy or breastfeeding.
  • Pantoprazole can interact with certain medicines, including some whose absorption depends on stomach acidity. Tell your prescriber about all medicines you take.
  • Do not change the dose or treatment duration without medical advice.
  • Seek medical evaluation for persistent symptoms, difficulty swallowing, unexplained weight loss, vomiting blood or black stools.

Dosage and Administration

Take Pantanu-I according to your healthcare professional’s instructions and the approved product label. The appropriate timing, frequency and duration depend on the patient’s condition and individual circumstances.

Because the formulation contains enteric-coated and sustained-release pellets, follow the product-specific administration directions. Do not crush, chew or open the capsule unless the approved instructions explicitly permit it.

Storage Instructions

Store Pantanu-I according to the conditions stated on the approved product packaging. Keep it in its original Alu-Alu pack, protected from excessive heat and moisture, and out of reach of children. Confirm the exact storage requirements from the product label.

Reviews

There are no reviews yet.

Be the first to review “Pantanu-I”

Your email address will not be published. Required fields are marked *